Morgan Stanley Molecular Partners Ag Transaction History
Morgan Stanley
- $1.36 Trillion
- Q1 2025
A detailed history of Morgan Stanley transactions in Molecular Partners Ag stock. As of the latest transaction made, Morgan Stanley holds 367 shares of MOLN stock, worth $1,313. This represents 0.0% of its overall portfolio holdings.
Number of Shares
367
Previous 367
-0.0%
Holding current value
$1,313
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding MOLN
# of Institutions
7Shares Held
3.58MCall Options Held
0Put Options Held
0-
Suvretta Capital Management, LLC New York, NY2.22MShares$7.95 Million0.38% of portfolio
-
Bvf Inc San Francisco, CA1.35MShares$4.85 Million0.23% of portfolio
-
Ubs Group Ag6.35KShares$22,7360.0% of portfolio
-
Rhumbline Advisers Boston, MA269Shares$9630.0% of portfolio
-
Bank Of America Corp Charlotte, NC157Shares$5620.0% of portfolio
About MOLECULAR PARTNERS AG
- Ticker MOLN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,514,000
- Market Cap $116M
- Description
- Molecular Partners AG operates as a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic proteins. Its products candidates include Abicipar, a DARPin therapeutic candidate, which is in Phase III clinical trials for the treatment of neovascular wet age-related macular degeneration, ...